| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Rega Institute for Medical Research, K.U. Leuven, B-3000 Leuven, Belgium
2Correspondence: Rega Institute for Medical Research, K.U. Leuven, Minderbroedersstraat 10, B-3000 Leuven, Belgium. E-mail: zeger.debyser{at}uz.kuleuven.ac.be
A synthetic gene encoding for HIV-1 integrase was designed to circumvent the intrinsic instability and the repressor elements present in the wild-type gene. High-level expression of HIV-1 integrase was obtained in various human cell lines independently of viral accessory proteins. A human 293T cell line was selected that stably expresses HIV-1 integrase and has growth kinetics comparable to the parental cell line. The enzyme was localized in the nucleus and remained stably associated with the chromosomes during mitosis. Lentiviral vector particles carrying the inactivating D64V mutation in the integrase gene were capable of stably transducing 293T cells when complemented in the producer cells with integrase expressed from the synthetic gene. When the cell line that stably expresses integrase was infected with the defective viral particles, complementation of integrase activity was detected as well. Expression of active HIV-1 integrase in human cells will facilitate the study of the interplay between host and viral factors during integration.—Cherepanov, P., Pluymers, W., Claeys, A., Proost, P., De Clercq, E., Debyser, Z. High-level expression of active HIV-1 integrase from a synthetic gene in human cells.
Key Words: complementation • expression • human immunodeficiency virus type 1
This article has been cited by other articles:
|
|
 |
|
  J. Rosenbluh, Z. Hayouka, S. Loya, A. Levin, A. Armon-Omer, E. Britan, A. Hizi, M. Kotler, A. Friedler, and A. Loyter Interaction between HIV-1 Rev and Integrase Proteins: A BASIS FOR THE DEVELOPMENT OF ANTI-HIV PEPTIDES J. Biol. Chem., May 25, 2007; 282(21): 15743 - 15753. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. R. Yant, Y. Huang, B. Akache, and M. A. Kay Site-directed transposon integration in human cells Nucleic Acids Res., April 1, 2007; 35(7): e50 - e50. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Cherepanov LEDGF/p75 interacts with divergent lentiviral integrases and modulates their enzymatic activity in vitro Nucleic Acids Res., January 12, 2007; 35(1): 113 - 124. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. De Rijck, L. Vandekerckhove, R. Gijsbers, A. Hombrouck, J. Hendrix, J. Vercammen, Y. Engelborghs, F. Christ, and Z. Debyser Overexpression of the Lens Epithelium-Derived Growth Factor/p75 Integrase Binding Domain Inhibits Human Immunodeficiency Virus Replication J. Virol., December 1, 2006; 80(23): 11498 - 11509. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Maroun, O. Delelis, G. Coadou, T. Bader, E. Segeral, G. Mbemba, C. Petit, P. Sonigo, J.-C. Rain, J.-F. Mouscadet, et al. Inhibition of Early Steps of HIV-1 Replication by SNF5/Ini1 J. Biol. Chem., August 11, 2006; 281(32): 22736 - 22743. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. N. Maertens, P. Cherepanov, and A. Engelman Transcriptional co-activator p75 binds and tethers the Myc-interacting protein JPO2 to chromatin J. Cell Sci., June 15, 2006; 119(12): 2563 - 2571. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Cherepanov, A. L. B. Ambrosio, S. Rahman, T. Ellenberger, and A. Engelman From the Cover: Structural basis for the recognition between HIV-1 integrase and transcriptional coactivator p75 PNAS, November 29, 2005; 102(48): 17308 - 17313. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Emiliani, A. Mousnier, K. Busschots, M. Maroun, B. Van Maele, D. Tempe, L. Vandekerckhove, F. Moisant, L. Ben-Slama, M. Witvrouw, et al. Integrase Mutants Defective for Interaction with LEDGF/p75 Are Impaired in Chromosome Tethering and HIV-1 Replication J. Biol. Chem., July 8, 2005; 280(27): 25517 - 25523. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Busschots, J. Vercammen, S. Emiliani, R. Benarous, Y. Engelborghs, F. Christ, and Z. Debyser The Interaction of LEDGF/p75 with Integrase Is Lentivirus-specific and Promotes DNA Binding J. Biol. Chem., May 6, 2005; 280(18): 17841 - 17847. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Vanegas, M. Llano, S. Delgado, D. Thompson, M. Peretz, and E. Poeschla Identification of the LEDGF/p75 HIV-1 integrase-interaction domain and NLS reveals NLS-independent chromatin tethering J. Cell Sci., April 15, 2005; 118(8): 1733 - 1743. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Lu, A. Limon, H. Z. Ghory, and A. Engelman Genetic Analyses of DNA-Binding Mutants in the Catalytic Core Domain of Human Immunodeficiency Virus Type 1 Integrase J. Virol., February 15, 2005; 79(4): 2493 - 2505. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Cherepanov, E. Devroe, P. A. Silver, and A. Engelman Identification of an Evolutionarily Conserved Domain in Human Lens Epithelium-derived Growth Factor/Transcriptional Co-activator p75 (LEDGF/p75) That Binds HIV-1 Integrase J. Biol. Chem., November 19, 2004; 279(47): 48883 - 48892. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Llano, M. Vanegas, O. Fregoso, D. Saenz, S. Chung, M. Peretz, and E. M. Poeschla LEDGF/p75 Determines Cellular Trafficking of Diverse Lentiviral but Not Murine Oncoretroviral Integrase Proteins and Is a Component of Functional Lentiviral Preintegration Complexes J. Virol., September 1, 2004; 78(17): 9524 - 9537. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Devroe, A. Engelman, and P. A. Silver Intracellular transport of human immunodeficiency virus type 1 integrase J. Cell Sci., November 1, 2003; 116(21): 4401 - 4408. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Maertens, P. Cherepanov, W. Pluymers, K. Busschots, E. De Clercq, Z. Debyser, and Y. Engelborghs LEDGF/p75 Is Essential for Nuclear and Chromosomal Targeting of HIV-1 Integrase in Human Cells J. Biol. Chem., August 29, 2003; 278(35): 33528 - 33539. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Cherepanov, G. Maertens, P. Proost, B. Devreese, J. Van Beeumen, Y. Engelborghs, E. De Clercq, and Z. Debyser HIV-1 Integrase Forms Stable Tetramers and Associates with LEDGF/p75 Protein in Human Cells J. Biol. Chem., January 3, 2003; 278(1): 372 - 381. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-Y. Fang, J. A. Mikovits, R. Bagni, C. L. Petrow-Sadowski, and F. W. Ruscetti Infection of Lymphoid Cells by Integration-Defective Human Immunodeficiency Virus Type 1 Increases De Novo Methylation J. Virol., October 15, 2001; 75(20): 9753 - 9761. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Baekelandt, A. Claeys, P. Cherepanov, E. De Clercq, B. De Strooper, B. Nuttin, and Z. Debyser DNA-Dependent Protein Kinase Is Not Required for Efficient Lentivirus Integration J. Virol., December 1, 2000; 74(23): 11278 - 11285. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Pluymers, N. Neamati, C. Pannecouque, V. Fikkert, C. Marchand, T. R. Burke Jr., Y. Pommier, D. Schols, E. De Clercq, Z. Debyser, et al. Viral Entry as the Primary Target for the Anti-HIV Activity of Chicoric Acid and Its Tetra-Acetyl Esters Mol. Pharmacol., September 1, 2000; 58(3): 641 - 648. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
